GI of Coconut Neera Syrup

To Estimate the Glycemic Index- GI of Coconut Neera Syrup - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/06/112605

Enrollment

Registered

2026-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Food product(s): Coconut Neera syrup: Test Product: Food product(s): Coconut neera syrup Dose: Food equivalent to 60.63gm carbohydrates. Route of Administration: Oral C

Eligibility

Inclusion criteria

Inclusion criteria: 1)Gender: Either male or non-pregnant, non-lactating female aged 18-60 years. 2)Subjects willing to give written informed consent 3)Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4)Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5)Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1.Diabetic Patients. 2.Subjects with a history of corticosteroid or birth control pill use in the last three months. 3.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 4.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 5.Have open sores or open lesions in the treatment areas. 6.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of such food product. 7.Have participated in any interventional clinical trial in the previous 30 days. 8.Have a known sensitivity to any of the constituents of the test product including sensitivities to (mention some of active ingredient s name) 9.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication i.e., biologics, including corticosteroids. 10.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Design outcomes

Primary

Measure	Time frame
Blood Glucose Assessment Day0(baseline), Day1, Day4Timepoint: At t0(Baseline), t15min, t30min, t45min, t60min, t90min, and t120 minutes	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results